MS SB2095

Establishes the Mississippi Medical Cannabis Act, authorizing medical cannabis use for patients with debilitating conditions including cancer, PTSD, epilepsy, Crohn's disease, and others, requiring a written certification from a registered practitioner and a registry identification card from the Department of Health

Assigns the Department of Health oversight of cultivation facilities, processing facilities, testing/research facilities, transportation and disposal entities, and patient/caregiver registry cards, while the Department of Revenue oversees dispensary licensing; licenses must begin being issued within 120–150 days of the act's effective date

Limits patients to 6 Mississippi Medical Cannabis Equivalency Units (MMCEUs) per week and 24 MMCEUs per 30 days, caps cannabis flower potency at 30% THC and tinctures/concentrates at 60% THC, and requires all products to carry harm notices and child-resistant packaging

Imposes a 5% excise tax on cultivation facility sales and standard 7% retail sales tax at dispensaries, allows municipalities and counties to opt out of cultivation, processing, sale, or distribution within 90 days of enactment, and deposits all fees, fines, and tax revenue into the State General Fund

Explicitly excludes medical cannabis establishments from eligibility for state economic development incentives, tax credits, ad valorem tax exemptions, and programs such as the ACE Fund, Mississippi Business Investment Act, Advantage Jobs Act, and Growth and Prosperity Act, while protecting banks providing financial services to licensed establishments from state liability